Chen CB - Search Results

1

Axitinib Rechallenge Restores the Anticancer Effect after Nivolumab: A Case Report.

Chang YS, Chang PH, Wang DH, Chen CB, Huang CF. Chang YS, et al. Among authors: chen cb. Int J Mol Sci. 2023 Jul 29;24(15):12149. doi: 10.3390/ijms241512149. Int J Mol Sci. 2023. PMID: 37569525 Free PMC article.

2

Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review.

Wang CY, Wang CW, Chen CB, Chen WT, Chang YC, Hui RC, Chung WH. Wang CY, et al. Among authors: chen cb, chen wt. Int J Mol Sci. 2023 Apr 15;24(8):7329. doi: 10.3390/ijms24087329. Int J Mol Sci. 2023. PMID: 37108492 Free PMC article. Review.

3

Attenuation of Wnt/β-catenin signaling in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Chen CB, Chang WC, Wu MY, Kao TY, Wang YW, Wang CW, Chen CJ, Chung WH, Su SC. Chen CB, et al. Among authors: chen cj. Int J Biol Sci. 2020 Jan 1;16(2):353-364. doi: 10.7150/ijbs.32331. eCollection 2020. Int J Biol Sci. 2020. PMID: 31929762 Free PMC article.

4

Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case-control cohort study.

Lu CW, Wang TY, Yen CF, Chen KH, Wu CE, Wang CL, Hsu PC, Fang YF, Li SH, Ko HW, Tseng LC, Shih FY, Lin YJ, Chen MJ, Chen CB, Su Pang JH, Chung WH, Ko YS. Lu CW, et al. Among authors: chen cb, chen kh, chen mj. Int J Dermatol. 2021 Feb;60(2):179-184. doi: 10.1111/ijd.15099. Epub 2020 Sep 25. Int J Dermatol. 2021. PMID: 32975313

5

The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies.

Wu CE, Yang CK, Peng MT, Huang PW, Chang CF, Yeh KY, Chen CB, Wang CL, Hsu CW, Chen IW, Lin CT, Ueng SH, Lin G, Lin YF, Cheng CY, Chang JW. Wu CE, et al. Among authors: chen iw, chen cb. BMC Cancer. 2020 Oct 21;20(1):1018. doi: 10.1186/s12885-020-07508-7. BMC Cancer. 2020. PMID: 33087090 Free PMC article.

6

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Era of Systems Medicine.

Chen CB, Wang CW, Chung WH. Chen CB, et al. Methods Mol Biol. 2022;2486:37-54. doi: 10.1007/978-1-0716-2265-0_3. Methods Mol Biol. 2022. PMID: 35437717

7

Keratosis pilaris-like eruptions in a child following COVID-19 vaccination.

Wu PC, Chung WH, Hung YT, Chen CB. Wu PC, et al. Among authors: chen cb. Int J Dermatol. 2023 Nov;62(11):e570-e571. doi: 10.1111/ijd.16810. Epub 2023 Aug 14. Int J Dermatol. 2023. PMID: 37580953 No abstract available.

8

Clinical characteristics and immune profiles of patients with immune-mediated alopecia associated with COVID-19 vaccinations.

Wang CW, Wu MY, Chen CB, Lin WC, Wu J, Lu CW, Chen WT, Wang FY, Hui RC, Chi MH, Chiu TM, Chang YC, Lin JY, Lin YY, Tsai WT, Hung SI, Chung WH. Wang CW, et al. Among authors: chen cb, chen wt. Clin Immunol. 2023 Oct;255:109737. doi: 10.1016/j.clim.2023.109737. Epub 2023 Aug 14. Clin Immunol. 2023. PMID: 37586672

9

Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer.

Hung SI, Chu MT, Hou MM, Lee YS, Yang CK, Chu SY, Liu FY, Hsu HC, Pao SC, Teng YC, Chen CB, Chao A, Chung WH, Chang JW, Lai CH. Hung SI, et al. Among authors: chen cb. Biomed Pharmacother. 2023 Dec 31;169:115928. doi: 10.1016/j.biopha.2023.115928. Epub 2023 Nov 26. Biomed Pharmacother. 2023. PMID: 38011788 Free article.

10

Brodalumab for the treatment of refractory Sweet syndrome.

Wu PC, Chen CB, Chung WH, Chi CC. Wu PC, et al. Among authors: chen cb. Int J Dermatol. 2024 May 10. doi: 10.1111/ijd.17197. Online ahead of print. Int J Dermatol. 2024. PMID: 38727206 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

378 results

Search Page